Lavem is a single-tablet HIV treatment combining tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and dolutegravir 50 mg. This is the combination known as TLD, South Africa’s standard first-line treatment for HIV. It is taken once daily, long term, and is available free at public health facilities.

What is Lavem?

Lavem is Schedule 4 — prescription-only — and contains three antiretroviral medicines in one tablet:

IngredientClass
Tenofovir disoproxil fumarate 300 mgNRTI (nucleotide reverse transcriptase inhibitor)
Lamivudine 300 mgNRTI (nucleoside reverse transcriptase inhibitor)
Dolutegravir 50 mgIntegrase inhibitor

This combination is widely called TLD — Tenofovir, Lamivudine, Dolutegravir — and it is South Africa’s recommended first-line HIV treatment. Equivalents include Acriptega and other generics. Being dispensed one rather than another is ordinary generic substitution.

HIV is treated with combinations rather than single medicines, because the virus replicates rapidly and mutates. A single medicine would select for resistant virus within weeks. Attacking three points in the life cycle at once makes resistance far less likely.

The three ingredients block two different stages:

Dolutegravir is what makes this combination effective. It works quickly, suppresses the virus reliably, has a high barrier to resistance, and is generally well tolerated — which is why it replaced efavirenz-based regimens in South African guidelines.

Treatment does not cure HIV, but it suppresses the virus so effectively that most people reach an undetectable viral load. Undetectable means untransmittable — someone with a sustained undetectable viral load cannot pass HIV on through sex. This is well established, and it is one of the most important things treatment achieves.

What is Lavem commonly used for?

A point worth being clear about, since people often ask: this combination is not the standard medicine for PrEP (pre-exposure prophylaxis, taken before exposure by HIV-negative people). PrEP in South Africa is normally tenofovir with emtricitabine, and there are now long-acting injectable options. PrEP and HIV treatment are different regimens with different monitoring, and taking a treatment regimen as PrEP without medical guidance is not appropriate.

Anyone should be tested for HIV before starting any of these. Taking treatment without knowing your status — or taking someone else’s tablets — risks resistance developing, which can compromise future treatment options.

HIV treatment is free at public health facilities in South Africa, along with testing and counselling. Cost should never be the reason someone goes without it.

How Lavem fits into this medicine category

ClassExamplesWhat it blocks
NRTIsTenofovir, lamivudine, emtricitabine, abacavirReverse transcriptase
NNRTIsEfavirenz, nevirapine, doravirineReverse transcriptase, differently
Integrase inhibitorsDolutegravir, raltegravirIntegrase
Protease inhibitorsLopinavir/ritonavir, atazanavirProtease, at assembly
Single-tablet regimensLavem, AcriptegaThree medicines combined

Single-tablet regimens matter more than convenience alone. Taking one tablet daily rather than several makes consistent adherence far easier, and consistent adherence is the single biggest factor in whether treatment works. See the HIV and antiviral medicines hub.

What to check before using Lavem

Take it at the same time every day. Missed doses allow the virus to replicate and are the main route to resistance. If you miss one, take it as soon as you remember unless it is nearly time for the next — do not double up.

Never stop without medical advice, and never run out. If you are travelling, changing clinics or your supply is running low, arrange a refill in advance.

Tell your doctor or pharmacist if you:

Possible cautions and when to ask a pharmacist or doctor

Common effects, usually mild and often settling in the first weeks, are headache, nausea, diarrhoea, tiredness and difficulty sleeping. Taking it in the morning sometimes helps if it disturbs sleep. Some people gain weight on dolutegravir-based regimens.

Seek medical attention if you develop:

Attend your monitoring appointments. Viral load and kidney function are checked periodically — viral load tells you whether treatment is working, and it is the number that matters most.

If you are struggling to take it consistently, say so. Side effects, stigma, travel, work patterns and mental health all affect adherence, and clinics deal with this routinely. Raising it early is far better than missed doses leading to resistance.

Related medicine guides

Frequently asked questions

What are Lavem tablets used for? Treating HIV infection. It combines tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and dolutegravir 50 mg — the combination known as TLD — in one daily tablet.

Are Lavem tablets used for PEP? A tenofovir/lamivudine/dolutegravir combination is used for post-exposure prophylaxis as a 28-day course, started as soon as possible after exposure and within 72 hours. It must be started by a healthcare provider.

Are Lavem tablets used for PrEP? No. PrEP in South Africa is normally tenofovir with emtricitabine, or a long-acting injectable. This is a treatment regimen, not a PrEP regimen.

Does it cure HIV? No, but it suppresses the virus. Most people reach an undetectable viral load, and undetectable means the virus cannot be passed on through sex.

What happens if I miss a dose? Take it as soon as you remember unless it is nearly time for the next — do not double up. Repeated missed doses risk resistance.

Why must I separate it from antacids and supplements? Calcium, magnesium, iron and zinc bind dolutegravir and stop it being absorbed. Take it at least 2 hours before or 6 hours after them.

Can I take it during pregnancy? Dolutegravir-based treatment is used in pregnancy in South Africa. Discuss it with your doctor, but do not stop treatment on your own.

Is HIV treatment free in South Africa? Yes, at public health facilities, along with testing and counselling.